The purpose of this research study is to investigate how and why the loss of muscle mass occurs with aging. Tissue collected from young subjects will be compared to previously collected tissue from elderly subjects, as well as previously collected data on muscle function/mass to further investigate cellular and molecular pathways that have recently been shown to be important for the aging process in muscle. The Principal Investigator (PI) and the study team will look for specific proteins (called biomarkers) that can be present in the muscle tissue in various amounts in different individuals. This study will increase the investigators understanding of the processes of muscle atrophy (loss of mass) and functional loss at older age and will help to find new treatments and interventions aimed at improving the quality of life and independence of America's rapidly expanding elderly population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Tumor Necrosis Factor alpha (TNF-alpha)
Timeframe: baseline
tumor-necrosis factor receptor-1 (TNFR1)
Timeframe: baseline
Phospho-Inhibitory Subunit Of NF-KBα (pIkBα)
Timeframe: baseline
Chemokine (C-C motif) ligand 2 (CCL2)
Timeframe: baseline
zinc transporter (ZIP) 14
Timeframe: baseline
Interleukin 6 (IL-6)
Timeframe: baseline
Interleukin (IL) 11β
Timeframe: baseline
Interleukin 8 (IL-8)
Timeframe: baseline
C-C chemokine receptor type 2 (CCR2)
Timeframe: baseline
zinc transporter 14 (ZIP14)
Timeframe: baseline
copper
Timeframe: baseline
zinc
Timeframe: baseline
iron
Timeframe: baseline
ribosome profiling
Timeframe: baseline